Managing the acute coronary syndrome patient: Evidence based recommendations for anti-platelet therapy-Reference-Cited by-同舟云学术

Managing the acute coronary syndrome patient: Evidence based recommendations for anti-platelet therapy

Published:2015-03 Issue:2 Volume:44 Page:141-149
ISSN:0147-9563
Container-title:Heart & Lung
language:en
Short-container-title:Heart & Lung

Author:

Clark Michael G.,Beavers Craig,Osborne John

Funder

AstraZeneca

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference50 articles.

1. 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Amsterdam;Circulation,2014

2. Acute coronary syndromes: diagnosis and management, Part I;Kumar;Mayo Clin Proc,2009

3. Acute coronary syndromes: pathophysiology, diagnosis and risk stratification;Hamm,2009

4. Heart disease and stroke statistics–2014 update: a report from the American Heart Association;Go;Circulation,2014

5. 2013 ACCF/AHA guideline for the management of st-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;O'Gara;J Am Coll Cardiol,2013

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International guideline comparison of lifestyle management for acute coronary syndrome and type 2 diabetes mellitus: A rapid review;Health Policy;2024-08

2. Comment on: Managing the Acute Coronary Syndrome Patient: Evidence Based Recommendations for Anti-Platelet Therapy;Current Problems in Cardiology;2023-10

3. Clopidogrel Resistance in a Murine Model of Diet-Induced Obesity Is Mediated by the Interleukin-1 Receptor and Overcome With DT-678;Arteriosclerosis, Thrombosis, and Vascular Biology;2020-06

4. Correlation between platelet thrombus formation on collagen-coated beads and platelet aggregation induced by ADP;Transfusion and Apheresis Science;2020-02

5. All-cause mortality, cardiovascular events, and health care costs after 12 months of dual platelet aggregation inhibition after acute myocardial infarction in real-world patients: findings from the Platelet-aggregation Inhibition: Persistence with treatment and cardiovascular Events in Real world (PIPER) study;Vascular Health and Risk Management;2018-11